Study supports use of remdesivir for COVID-19 patients on low-flow oxygen or no oxygen
Research boosts case for new gene therapy to treat severe form of epilepsy
18 January 2022New data suggests that pandemic resulted in temporary decline in number of babies born in United Kingdom
18 January 2022Study supports use of remdesivir for COVID-19 patients on low-flow oxygen or no oxygen
Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.
